Antithrombotic Activities of Luteolin In Vitro and In Vivo

J Biochem Mol Toxicol. 2015 Dec;29(12):552-8. doi: 10.1002/jbt.21726. Epub 2015 Jul 16.

Abstract

The objectives of present study were to investigate whether luteolin affects procoagulant proteinase activity and fibrin clot formation and influences thrombosis and coagulation in Sprague-Dawle rats. Luteolin significantly inhibited the enzymatic activity of thrombin and FXa activity by 29.1% and 16.2%. Luteolin also inhibited fibrin polymer formation in turbidity and microscopic analysis using fluorescent conjugate. Coagulation assay of luteolin was found to prolong activated partial thromboplastin time and prothrombin time. Moreover, luteolin protected the development of oxidative stress induced thrombosis in the FeCl3 -induced carotid arterial thrombus model. This study demonstrated that luteolin may be useful by reducing or preventing thrombotic challenge and can help us better understand the antithrombotic action of luteolin.

Keywords: Anticoagulant; Antithrombotic; Bioflavonoid; Luteolin; Thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antithrombins / pharmacology*
  • Blood Coagulation Factors / metabolism
  • Carotid Arteries / pathology
  • In Vitro Techniques
  • Luteolin / pharmacology*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Thrombosis / prevention & control*

Substances

  • Antithrombins
  • Blood Coagulation Factors
  • Luteolin